SNDX - Syndax Pharmaceuticals Inc
IEX Last Trade
12.88
-0.100 -0.776%
Share volume: 75,724
Last Updated: Thu 26 Dec 2024 08:30:12 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$12.98
-0.10
-0.77%
Summary score
29%
Profitability
38%
Dept financing
4%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2018 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.4%
Return on assets
-10.55%
Return on sales
-4018.23%
Return on invested capital
83.78%
Total debt ratio
25.2%
Debt ratio change over timeo
-0.76%
Current Ratio
10.5%
Quick Ratio
10.5%
Cash Position Ratio
10.23%
Short-term ratios 30-Sep-2021 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1.8%
Return on assets
-1.62%
Return on sales
75.65%
Return on invested capital
12.12%
Total debt ratio
9.36%
Debt ratio change over timeo
-0.96%
Current Ratio
16.33%
Quick Ratio
16.33%
Cash Position Ratio
16.02%
Last quarter ratios 30-Sep-2022
The data are presented for the financials results of the last quarter.
Return on equity
-10.47%
Return on assets
-9.77%
Return on sales
0%
Return on invested capital
188.85%
Total debt ratio
6%
Debt ratio change over time
-0.97%
Current Ratio
17.19%
Quick Ratio
17.19%
Cash Position Ratio
16.86%
Performance ratios (change over 4 years) 30-Sep-2018 - 30-Sep-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-117.71%
Return on assets
-111.61%
Return on sales
-3880.13%
Return on invested capital
1.32%
Total debt ratio
-76.22%
Debt ratio change over time
-0.76%
Current Ratio
6.21%
Quick Ratio
6.21%
Cash Position Ratio
5.99%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SNDX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.4% | 2.13% | 31.88% | 8.11% |
| Return on assets | -10.55% | 3.01% | 3.77% | 6.05% |
| Return on sales | -4018.23% | 29.12% | 37.99% | 40.29% |
| Return on invested capital | 83.78% | 3.96% | 7.33% | 21.06% |
| Profitability | 25% | 33% | 66% | 63% |
| Total debt ratio | 25.2% | 98.45% | 86.51% | 27.94% |
| Debt ratio change over time | -0.76% | 271.43% | 13.5% | 1.23% |
| Dept financing | 6% | 50% | 23% | 7% |
| Current Ratio | 16.33% | 0.85% | 1.56% | 4.7% |
| Quick Ratio | 16.33% | 0.75% | 1.22% | 4.02% |
| Cash Position Ratio | 16.02% | 0.29% | 0.63% | 2.18% |
| Liquididy | 75% | 7% | 10% | 21% |
| Short-term ratios | SNDX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -1.8% | 21.1% | 75.65% | 6.76% |
| Return on assets | -1.62% | 3.24% | 3.96% | 6.08% |
| Return on sales | 75.65% | 32.22% | 38.74% | 45.24% |
| Return on invested capital | 12.12% | 4.08% | 6.25% | 16.11% |
| Profitability | 44% | 37% | 64% | 67% |
| Total debt ratio | 9.36% | 89.14% | 94.42% | 24.28% |
| Debt ratio change over time | -0.96% | 31.78% | 14.87% | 0.8% |
| Dept financing | 2% | 49% | 37% | 7% |
| Current Ratio | 16.33% | 0.85% | 1.56% | 4.7% |
| Quick Ratio | 16.33% | 0.75% | 1.22% | 4.02% |
| Cash Position Ratio | 16.02% | 0.29% | 0.63% | 2.18% |
| Liquididy | 75% | 3% | 5% | 17% |